These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 19723111)
1. Biological effects of a new vacuolar-H,-ATPase inhibitor in colon carcinoma cell lines. Supino R; Scovassi AI; Croce AC; Dal Bo L; Favini E; Corbelli A; Farina C; Misiano P; Zunino F Ann N Y Acad Sci; 2009 Aug; 1171():606-16. PubMed ID: 19723111 [TBL] [Abstract][Full Text] [Related]
2. Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies. Supino R; Petrangolini G; Pratesi G; Tortoreto M; Favini E; Bo LD; Casalini P; Radaelli E; Croce AC; Bottiroli G; Misiano P; Farina C; Zunino F J Pharmacol Exp Ther; 2008 Jan; 324(1):15-22. PubMed ID: 17909082 [TBL] [Abstract][Full Text] [Related]
3. Effect of a novel vacuolar-H+-ATPase inhibitor on cell and tumor response to camptothecins. Petrangolini G; Supino R; Pratesi G; Dal Bo L; Tortoreto M; Croce AC; Misiano P; Belfiore P; Farina C; Zunino F J Pharmacol Exp Ther; 2006 Sep; 318(3):939-46. PubMed ID: 16714402 [TBL] [Abstract][Full Text] [Related]
4. Expression of Vacuolar H+-ATPases and the intracellular pH values in three adenocarcinoma cell lines of digestive system. Zou XP; Chen M; Zhang XQ; Zhang B; Cao J; Luo HS Cell Mol Biol (Noisy-le-grand); 2010 Mar; 56 Suppl():OL1268-75. PubMed ID: 20385078 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells. Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274 [TBL] [Abstract][Full Text] [Related]
6. The dual mechanism of the antifungal effect of new lysosomotropic agents on the Saccharomyces cerevisiae RXII strain. Krasowska A; Chmielewska L; Łuczyński J; Witek S; Sigler K Cell Mol Biol Lett; 2003; 8(1):111-20. PubMed ID: 12655364 [TBL] [Abstract][Full Text] [Related]
7. Direct recruitment of H+-ATPase from lysosomes for phagosomal acidification. Sun-Wada GH; Tabata H; Kawamura N; Aoyama M; Wada Y J Cell Sci; 2009 Jul; 122(Pt 14):2504-13. PubMed ID: 19549681 [TBL] [Abstract][Full Text] [Related]
8. Plasmalemmal vacuolar-type H+-ATPase in cancer biology. Sennoune SR; Luo D; Martínez-Zaguilán R Cell Biochem Biophys; 2004; 40(2):185-206. PubMed ID: 15054222 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and identification of cytotoxic diphyllin glycosides as vacuolar H(+)-ATPase inhibitors. Zhang Z; Ma J; Zhu L; Zhao Y Eur J Med Chem; 2014 Jul; 82():466-71. PubMed ID: 24929344 [TBL] [Abstract][Full Text] [Related]
10. Desipramine induces apoptotic cell death through nonmitochondrial and mitochondrial pathways in different types of human colon carcinoma cells. Arimochi H; Morita K Pharmacology; 2008; 81(2):164-72. PubMed ID: 18025841 [TBL] [Abstract][Full Text] [Related]
11. Dissection of autophagy in tobacco BY-2 cells under sucrose starvation conditions using the vacuolar H(+)-ATPase inhibitor concanamycin A and the autophagy-related protein Atg8. Yano K; Yanagisawa T; Mukae K; Niwa Y; Inoue Y; Moriyasu Y Plant Signal Behav; 2015; 10(11):e1082699. PubMed ID: 26368310 [TBL] [Abstract][Full Text] [Related]
12. Vacuolar ATPase-mediated sequestration of local anesthetics in swollen macroautophagosomes. Bawolak MT; Morissette G; Marceau F Can J Anaesth; 2010 Mar; 57(3):230-9. PubMed ID: 20054683 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of H+-vacuolar ATPase by the energy blocker 3-bromopyruvate, a new antitumour agent. Dell'Antone P Life Sci; 2006 Oct; 79(21):2049-55. PubMed ID: 16908033 [TBL] [Abstract][Full Text] [Related]
14. Vacuolar ATPase in phago(lyso)some biology. Kissing S; Saftig P; Haas A Int J Med Microbiol; 2018 Jan; 308(1):58-67. PubMed ID: 28867521 [TBL] [Abstract][Full Text] [Related]
15. Receptor-independent, vacuolar ATPase-mediated cellular uptake of histamine receptor-1 ligands: possible origin of pharmacological distortions and side effects. Morissette G; Lodge R; Bouthillier J; Marceau F Toxicol Appl Pharmacol; 2008 Jun; 229(3):320-31. PubMed ID: 18328520 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of Cleistanthin A Derivatives as Potent Vacuolar H(+) -ATPase Inhibitors. Zhao Y; Lu Y; Ma J; Zhu L Chem Biol Drug Des; 2015 Oct; 86(4):691-6. PubMed ID: 25677205 [TBL] [Abstract][Full Text] [Related]
17. Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase. Pereira CS; Guedes JP; Gonçalves M; Loureiro L; Castro L; Gerós H; Rodrigues LR; Côrte-Real M Oncotarget; 2016 Sep; 7(38):62144-62158. PubMed ID: 27556694 [TBL] [Abstract][Full Text] [Related]
18. TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells. Lozupone F; Borghi M; Marzoli F; Azzarito T; Matarrese P; Iessi E; Venturi G; Meschini S; Canitano A; Bona R; Cara A; Fais S Oncogene; 2015 Oct; 34(40):5163-74. PubMed ID: 25659576 [TBL] [Abstract][Full Text] [Related]
19. Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: procainamide-induced autophagic cell vacuolization. Morissette G; Lodge R; Marceau F Toxicol Appl Pharmacol; 2008 May; 228(3):364-77. PubMed ID: 18295291 [TBL] [Abstract][Full Text] [Related]
20. A new destruxin as inhibitor of vacuolar-type H+-ATPase of Saccharomyces cerevisiae. Vázquez MJ; Albarrán MI; Espada A; Rivera-Sagredo A; Díez E; Hueso-Rodríguez JA Chem Biodivers; 2005 Jan; 2(1):123-30. PubMed ID: 17191925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]